Go Pro
→ Why the Treasury still prices gold at 42 dollars an ounce (From Golden Portfolio) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.26
-1.8%		$0.27
$0.22
▼
$2.10
$31.29M1.391.96 million shs433,637 shs
Modular Medical, Inc. stock logo
MODD
Modular Medical
$2.82
-23.4%		$3.19
$1.72
▼
$30.00
$22.98M0.45122,946 shs227,098 shs
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$4.58
$4.55
$4.26
▼
$4.69
$9.44M1.8210,370 shsN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
$0.83
+1.0%		$0.75
$0.50
▼
$1.73
$37.27M1.36179,854 shs121,406 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
0.00%+1.44%-6.39%-20.33%-82.33%
Modular Medical, Inc. stock logo
MODD
Modular Medical
0.00%-2.13%+67.27%-21.20%-82.87%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
0.00%0.00%0.00%0.00%+0.66%
TELA Bio, Inc. stock logo
TELA
TELA Bio
0.00%+11.31%-5.56%-12.16%-48.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.26
-1.8%		$0.27
$0.22
▼
$2.10
$31.29M1.391.96 million shs433,637 shs
Modular Medical, Inc. stock logo
MODD
Modular Medical
$2.82
-23.4%		$3.19
$1.72
▼
$30.00
$22.98M0.45122,946 shs227,098 shs
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$4.58
$4.55
$4.26
▼
$4.69
$9.44M1.8210,370 shsN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
$0.83
+1.0%		$0.75
$0.50
▼
$1.73
$37.27M1.36179,854 shs121,406 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
0.00%+1.44%-6.39%-20.33%-82.33%
Modular Medical, Inc. stock logo
MODD
Modular Medical
0.00%-2.13%+67.27%-21.20%-82.87%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
0.00%0.00%0.00%0.00%+0.66%
TELA Bio, Inc. stock logo
TELA
TELA Bio
0.00%+11.31%-5.56%-12.16%-48.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accuray Incorporated stock logo
ARAY
Accuray
1.67
Reduce$2.00663.36% Upside
Modular Medical, Inc. stock logo
MODD
Modular Medical
1.00
SellN/AN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
0.00
N/AN/AN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.40
Hold$2.20165.03% Upside

Current Analyst Ratings Breakdown

Latest NURO, TELA, ARAY, and MODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/4/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/17/2026
TELA Bio, Inc. stock logo
TELA
TELA Bio
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/8/2026
Accuray Incorporated stock logo
ARAY
Accuray
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
6/24/2026
Modular Medical, Inc. stock logo
MODD
Modular Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accuray Incorporated stock logo
ARAY
Accuray
$401.95M0.08N/AN/A$0.35 per share0.75
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/A$2.78 per shareN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$3.03M3.11N/AN/A$13.18 per share0.35
TELA Bio, Inc. stock logo
TELA
TELA Bio
$80.28M0.46N/AN/A$0.16 per share5.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accuray Incorporated stock logo
ARAY
Accuray
-$49.19M-$0.40N/AN/AN/A-12.24%-97.85%-10.82%11/4/2026 (Estimated)
Modular Medical, Inc. stock logo
MODD
Modular Medical
-$28.24M-$8.69N/AN/AN/AN/A-292.14%-222.79%N/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
-$6.53M-$4.59N/AN/AN/A-203.71%-42.56%-39.26%N/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$38.83M-$0.77N/AN/AN/A-51.53%-1,320.81%-59.39%11/12/2026 (Estimated)

Latest NURO, TELA, ARAY, and MODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2026Q4 2026
Accuray Incorporated stock logo
ARAY
Accuray
-$0.03-$0.02+$0.01-$0.02$105.30 million$100.92 million
8/14/2026Q1 2027
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/A-$1.19N/A-$1.19N/AN/A
8/10/2026Q2 2026
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$0.1738-$0.20-$0.0262-$0.20$20.01 million$19.29 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/AN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/AN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Accuray Incorporated stock logo
ARAY
Accuray
3.51
1.50
0.74
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/A
3.25
3.25
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/A
13.88
12.70
TELA Bio, Inc. stock logo
TELA
TELA Bio
8.82
2.99
2.38

Institutional Ownership

CompanyInstitutional Ownership
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
Modular Medical, Inc. stock logo
MODD
Modular Medical
27.47%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
19.40%
TELA Bio, Inc. stock logo
TELA
TELA Bio
94.35%

Insider Ownership

CompanyInsider Ownership
Accuray Incorporated stock logo
ARAY
Accuray
2.40%
Modular Medical, Inc. stock logo
MODD
Modular Medical
7.10%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
7.30%
TELA Bio, Inc. stock logo
TELA
TELA Bio
5.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accuray Incorporated stock logo
ARAY
Accuray
1,040119.44 million116.57 millionOptionable
Modular Medical, Inc. stock logo
MODD
Modular Medical
208.15 million7.57 millionNot Optionable
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
202.06 million1.90 millionNot Optionable
TELA Bio, Inc. stock logo
TELA
TELA Bio
12044.90 million42.61 millionOptionable

Recent News About These Companies

TELA Bio chief operating officer and chief financial officer resigns
September 2, 2026  |  pennbizreport.comP
Tela Bio cuts 41 jobs in Malvern as new CEO launches $17M cost-reduction plan
September 2, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/tela-bio-cuts-41-jobs-in-malvern-as-new-ceo-launches-17m-cost-reduction-plan/ar-AA2bq9pz
Malvern medical-tech company is slashing jobs as part of cost-cutting campaign
September 1, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/malvern-medical-tech-company-is-slashing-jobs-as-part-of-cost-cutting-campaign/ar-AA2bmQRb
Malvern firm cutting 20% of workforce as new CEO launches cost cuts
August 31, 2026  |  bizjournals.comhttps://www.bizjournals.com/philadelphia/news/2026/08/31/tela-bio-malvern-layoffs-medical-technology-getz.html
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353166/0/en/tela-bio-announces-coo-cfo-transition-and-strategic-cost-reduction-initiative.html
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
August 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tela-bio-tela-q2-2026-130128267.html
Heather Getz Acquires 15,000 Shares of TELA Bio (NASDAQ:TELA) Stock
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tela-insider-buying-and-selling-2026-08-18/
Tela Bio outlines 9- to 12-month sales ramp while withdrawing full-year revenue guidance
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4630432-tela-bio-outlines-9-to-12-month-sales-ramp-while-withdrawing-full-year-revenue-guidance
TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934332-tela-bio-inc-tela-q2-2026-earnings-call-transcript
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
August 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972324/tela-bio-inc-tela-reports-q2-loss-lags-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2972324
TELA Bio Reports Second Quarter 2026 Financial Results
August 10, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/tela-bio-reports-second-quarter-2026-financial-results-1036437897
Tela Bio names new CEO as Malvern medtech company eyes next growth phase
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/executive-leadership-and-management/tela-bio-names-new-ceo-as-malvern-medtech-company-eyes-next-growth-phase/ar-AA29sPgK
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339679/0/en/tela-bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
Tela Bio names new CEO as co-founder exits after 14 years
August 4, 2026  |  bizjournals.comhttps://www.bizjournals.com/philadelphia/news/2026/08/04/tela-bio-heather-getz-antony-koblish-malvern-ceo.html
TELA Bio Appoints Heather Getz as Chief Executive Officer and Director
August 4, 2026  |  quiverquant.comQ
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338144/0/en/tela-bio-announces-appointment-of-heather-getz-as-chief-executive-officer-and-director.html
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335566/0/en/tela-bio-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference.html
TELA Bio to Announce Second Quarter 2026 Financial Results
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3330090/0/en/tela-bio-to-announce-second-quarter-2026-financial-results.html
A perfect match
July 16, 2026  |  bbc.comB
TELA Bio Healthcare Story Faces New Market Scrutiny
May 15, 2026  |  kalkinemedia.comK

New MarketBeat Followers Over Time

Media Sentiment Over Time

Accuray stock logo

Accuray NASDAQ:ARAY

$0.26 0.00 (-1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$0.26 +0.00 (+0.38%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Modular Medical stock logo

Modular Medical NASDAQ:MODD

$2.82 -0.86 (-23.37%)
Closing price 04:00 PM Eastern
Extended Trading
$3.24 +0.43 (+15.07%)
As of 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

NeuroMetrix stock logo

NeuroMetrix NASDAQ:NURO

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

TELA Bio stock logo

TELA Bio NASDAQ:TELA

$0.83 +0.01 (+1.05%)
Closing price 04:00 PM Eastern
Extended Trading
$0.84 +0.01 (+0.83%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas